|Slideshows|March 4, 2020

The Role of Psychiatrists During the Coronavirus Outbreak

Emerging infectious disease outbreaks cause significant fear and uncertainty. Psychiatrists can play an important role in supporting the well-being of patients and families, health care personnel, and the general public.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

New Research Explores the Genetic Roots of Hair-Pulling and Skin-Picking, Connection to OCD

ByLeah Kuntz

August 31st 2026

Phase 2 Trial of Bezisterim for Neurological Symptoms of Long COVID: Treatment Phase Completed

ByLeah Kuntz

August 31st 2026

Patent Application Published: MDMA-N-Acylethanolamines for the Treatment of PTSD, Anxiety, and Eating Disorders

ByLeah Kuntz

August 24th 2026

Collaborative Psychiatric-Dermatologic Care Improves Outcomes for Complex Patients

ByJames A. Bourgeois, OD, MD,Xiaofeng Yan, MD, PhD

August 21st 2026

How Does the Skin-Brain Connection Drive Skin-Picking Disorder?

ByJames A. Bourgeois, OD, MD,Xiaofeng Yan, MD, PhD

August 20th 2026

Latest CME

In-Person Event

Jersey City Psychiatry

October 2-3, 2026

Register now!

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Gus Alva, MD, DFAPA; Erin Crown, MHS, PA-C

The Role of Psychiatrists During the Coronavirus Outbreak

Related Content

New Research Explores the Genetic Roots of Hair-Pulling and Skin-Picking, Connection to OCD

Phase 2 Trial of Bezisterim for Neurological Symptoms of Long COVID: Treatment Phase Completed

Patent Application Published: MDMA-N-Acylethanolamines for the Treatment of PTSD, Anxiety, and Eating Disorders

Collaborative Psychiatric-Dermatologic Care Improves Outcomes for Complex Patients

How Does the Skin-Brain Connection Drive Skin-Picking Disorder?

Latest CME

Jersey City Psychiatry

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Trending on Psychiatric Times

When Treatment-Resistant Depression Means Mismatched: Rethinking Difficult-to-Treat Depression

Brain Trust: Anita H. Clayton, MD, on Diagnosing and Treating Sexual Dysfunction

Repurposing Dopamine Agonist Pramipexole for Disabling Anhedonia

The Year So Far in GLP-1s: What Psychiatric Clinicians Need to Know

GLP-1 Receptor Agonists Linked to Lower Mortality, Cardiovascular Events in Serious Mental Illness